HealthTech in venture capital encompasses investments in technology-based healthcare products and services that can be delivered outside traditional healthcare settings. It includes innovations aimed at improving the quality of treatment and optimising healthcare processes, as well as projects related to hospital management.
How does venture capital contribute to the development of technology in health care?
Venture capitalists provide capital to startups developing new technologies, from telemedicine to artificial intelligence for diagnostics. This enables research, prototyping, and the delivery of innovative products to the market. For example, investment in AI in medicine is enabling the development of more accurate diagnostic systems and personalised therapies.
In addition to funding, venture capitalists help startups scale their solutions and enter new markets. Startups can use these resources to expand their products globally.
Venture capital investment is also accelerating the digitalisation of healthcare. Technologies such as electronic health records, patient monitoring systems and mobile health apps are attracting significant amounts of capital. For example, the digital health market is expected to grow 21.9% over the next six years and reach $946 billion by 2030, driven in part by investment in digital solutions.
VCs are investing in startups that expand access to healthcare services through telemedicine and mobile technology. This allows healthcare services to be provided in remote regions where there is a shortage of doctors. Platforms such as MyDoc have been able to grow rapidly thanks to VC investment, increasing the number of users by 160 per cent during the pandemic in 2020.
What is HealthTech?
HealthTech is an industry that combines medicine with innovative technologies to improve diagnosis, treatment, health management and patient monitoring. It covers various solutions, from telemedicine to biotechnology and wearable devices. HealthTech also uses digital technology, artificial intelligence, data analytics and other tools to make healthcare more accessible, accurate and personalised.
Popular HealthTech verticals
- Telemedicine. This includes the remote delivery of healthcare services through video consultations, mobile apps, and platforms. This vertical has grown in popularity, especially after the COVID-19 pandemic, when demand for remote healthcare services increased;
- Devices and remote monitoring. This refers to fitness trackers and smartwatches that allow users to monitor their health in real-time. These technologies are used to monitor heart health, blood oxygen levels and other key indicators to help doctors provide personalised care;
- Artificial Intelligence. AI is being used to analyse medical images, detect disease at an early stage, develop new treatments, predict treatment outcomes and create personalised care plans;
- Electronic medical records (EMRs) and patient management systems. Making it easier to store, access and analyse patients' medical data, giving doctors full access to a patient's history and enabling better coordination of care;
- Biotechnology and genomics. Using the latest technologies to study genetic data, enabling the development of personalised treatments for diseases such as cancer-based on a patient's genetic characteristics;
- Digital therapeutics. Provides software solutions to treat or manage chronic diseases. For example, mobile apps can help patients with diabetes or cardiovascular disease monitor their condition and adhere to treatment plans.
Healthcare and the COVID-19 Pandemic
The COVID-19 pandemic was an important moment for the healthcare industry and venture capital, accelerating investment in technologies that could help solve pressing problems in medical systems around the world. Several key changes occurred during this period that impacted the industry.
First, there was an increase in HealthTech investment. During the pandemic, venture capitalists focused on companies offering solutions for remote healthcare, chronic disease management and diagnostics. Telemedicine, for example, became a major area of investment because it allowed patients to receive medical advice without having to physically visit a hospital.
Second, the demand for digital solutions increased. The pandemic demonstrated the importance of digital solutions for continuity of treatment. Governments and private companies quickly invested in developing infrastructure to support digital services, such as electronic medical records (EMRs), mobile applications for health monitoring, and artificial intelligence for disease diagnosis.
This has led to a change in consumer behaviour and a focus on telemedicine. COVID-19 has changed the way patients interact with healthcare services. Remote consultations have become the norm, fuelling the growth of platforms such as Teladoc and other video consultation and remote patient monitoring services.
In addition to solutions to combat COVID-19, investors have also turned their attention to companies offering innovations in chronic disease management. For example, the use of digital technology to manage diabetes, cardiovascular disease and other chronic conditions has received significant investment. Companies offering solutions for remote patient monitoring have been boosted.
Modern healthcare opportunities
Technological innovations are transforming medicine, creating new possibilities to improve patient care, diagnosis, and treatment. Here are a few examples.
Artificial intelligence in healthcare
Artificial intelligence has huge potential to improve the healthcare industry. AI is used to analyse large amounts of data, identify patterns and support decision-making in diagnosis, therapy, and prognosis. Some key applications include:
- AI helps automate the analysis of medical images (MRI, CT scans), allowing doctors to identify diseases such as cancer or cardiovascular disorders more quickly and accurately;
- AI can analyse genomic and medical data to tailor treatment regimens based on each patient's unique characteristics;
- AI can predict the likelihood of certain diseases, such as diabetes or heart attack, based on a patient's behavioural and medical data.
Drug discovery
Technology is helping to speed up the process of developing new medicines. It used to take years, but the use of AI and biotechnology is making the process of finding and testing drugs faster and more efficient.
AI makes it possible to screen millions of chemical compounds in a short time and analyse their efficacy and toxicity, reducing the time and cost of drug discovery.
Besides, the technology can streamline and automate data collection during clinical trials, speeding up decisions on drug safety.
Clinical documentation
Automation and intelligent data processing systems are helping doctors manage medical records more efficiently. Artificial intelligence can capture and process medical data in real-time, reducing the burden on doctors and minimising errors.
AI can also quickly process large amounts of clinical data to aid diagnosis and treatment selection, making it easier to access a patient's medical history and relevant recommendations.
Weight loss products
Another key area in HealthTech is weight loss. Obesity is a major problem for the global healthcare system, and new technology-based therapies aim to help people control their weight. For example, GLP-1-based drugs (such as semaglutide) have been shown to help patients lose weight by controlling appetite.
The future of HealthTech
The future of HealthTech promises to revolutionise the way healthcare is delivered, making it more efficient and affordable. Key trends shaping the future of HealthTech include artificial intelligence, genomics, digital therapies, biomedical sensors and telemedicine. Let's try to visualise where HealthTech could be heading in this decade:
Artificial Intelligence (AI) and Machine Learning. In the future, AI will help doctors make faster and more accurate decisions by automating the analysis of images, electronic patient records and genomic data;
Telemedicine. Future telemedicine capabilities will include more integrated, real-time health monitoring systems using wearable devices and biosensors. Patients will be able to continuously transmit data to their doctors, which will improve the monitoring of chronic diseases;
Genomics and personalised medicine. In the future, personalised medicine will be based on individual genomic data, allowing the development of medicines that are best suited to each patient. This will significantly increase the effectiveness of treatment and reduce side effects;
Biosensors and wearable devices. Wearable devices and sensors for monitoring biomarkers (heart rate, blood glucose, oxygen saturation) are becoming more accurate and widely used. In the future, the development of these technologies will enable people to continuously monitor their health and provide doctors with more detailed and regular data to improve diagnosis and treatment.
HealthTech regulation and the legal environment in Ukraine and globally
Clear HealthTech regulation plays a key role in attracting venture capital investment. In Ukraine, the regulatory framework is developing rapidly and aligning with international standards. Since 2015, the country has been moving towards convergence with EU norms. Consequently, new medical products can be introduced to the market, provided they comply with technical regulations.
Data and privacy: Ukraine has a basic law on personal data protection, which is being modernised to align with EU standards. Medical data is sensitive, so processing it requires special conditions and patient consent.
Telemedicine: In 2023, a law on the fundamentals of telemedicine was adopted. This law approved the principles of providing remote medical services, authorised the participation of foreign doctors, and set out the rights and obligations of patients and medical institutions in this area.
International context: Startups need to consider regulations in other countries. In the EU, for example, there is the MDR, while in the US, there is the FDA. Adhering to international quality and safety standards fosters investor confidence and facilitates growth.
Ethical and legal challenges in HealthTech
Privacy and patient data. Startups must protect data, use encryption and be transparent. It is important to implement privacy by design principles.
Fair access. HealthTech solutions must be inclusive. Digital inequality can exacerbate social divisions.
Physicians and developers must be held accountable. Doctors are responsible for treatment, but manufacturers can be sued for software errors. Currently, there is no clear division of responsibility between doctors and developers.
Ethical dilemmas of AI. Avoiding biased algorithms, ensuring decisions are explainable and obtaining informed consent all require regulatory and moral consideration.
ESG factors and sustainability: the impact of HealthTech
Environmental factor: Telemedicine reduces emissions, and digitalisation reduces paper use. It is essential to control e-waste.
Social factors: It improves health and inclusiveness and supports the public good. HealthTech can help to achieve the UN SDGs.
Governance: It promotes transparency, compliance and ethical algorithms. Strong governance builds trust in a startup.
The Role of Education, Science and Infrastructure
Education: Ukraine produces many IT specialists, but more programmes at the intersection of medicine and technology are needed. Modernising universities, offering grants and internships, and retaining talent are important.
Science: Development requires the integration of academic science with industry and the commercialisation of developments, as well as participation in international grants and consortia.
Infrastructure: The eHealth system in Ukraine is developing rapidly. The rehabilitation of hospitals and digitalisation following destruction caused by the war creates a window of opportunity for introducing new solutions.
Key risks and challenges of venture capital investment in HealthTech
Market risks include difficult monetisation, a long sales cycle and a limited domestic market.
Clinical and technological risks include the need for an evidence base and certification, and the high risk of the MVP not working.
Regulatory risks include constant regulatory changes, lengthy procedures and difficulties with international certification.
Reputational risks include data leaks, PR mistakes and mistrust among doctors and patients.
Human resources: lack of multidisciplinary teams, outflow of specialists and high competition for talent.
Exit: difficulty scaling up, need for localisation, limited examples of successful exits.
Conclusions
Venture capital (VC) plays a crucial role in funding HealthTech innovation by providing startups with resources to develop, research and deploy new technologies.
The COVID-19 pandemic has significantly increased interest in HealthTech due to the need for fast and efficient solutions for remote patient treatment and monitoring. Venture investment is focused on technologies such as telemedicine, wearable devices, and artificial intelligence (AI) for diagnostics and genomics. This is driving the development of new solutions that make healthcare more personalised and accessible.
The promise of AI and machine learning in healthcare is already becoming a reality: from analysing medical images to predicting disease and supporting personalised treatment.
